In the case of the examination of myeloid (BDCA-1+CD19−) dendritic cells (mDCs), we detected a lower percentage of BDCA-1+CD19+DCs in the PB of patients with endometrial cancer in comparison to the control group and the reference group. Here, CD19 is linked to endometrial cancer.